EPIX
insider transactionsESSA Pharma Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-156
0 buy · 156 sell
Net value · 365d
-$293
$0 in · $293 out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
3
0 buy · 156 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Other·U
TenPercentOwner
—
11.5M sh · 3 lots
-
Other·D
Wood David S. KEY
Chief Financial Officer
—
33.3K sh
Own -100%
-
Other·D
Director
—
43.2K sh
Own -100%
-
Other·D
Director
—
30.0K sh
Own -100%
-
Other·D
Director
—
2.9K sh
Own -100%
-
Other·D
Director
—
784.4K sh
Own -100%
-
Other·D
President and CEO
—
65.7K sh
Own -100%
-
Other·D
Director
—
14.3K sh
Own -100%
-
Exercise·X
TenPercentOwner
$0
2.9M sh · 3 lots
Own New
-
Exercise·X
TenPercentOwner
$0
2.9M sh · 3 lots
Own New
-
Sell·S
TenPercentOwner
$293
156 sh · $1.88 avg · 3 lots
Own -0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2025 | BVF INC/IL | Other U | 11.5M3 lots | — |
| Oct 9, 2025 | Wood David S. KEY | Other D | 33.3K | — |
| Oct 9, 2025 | Glickman Richard M | Other D | 43.2K | — |
| Oct 9, 2025 | Requadt Scott | Other D | 30.0K | — |
| Oct 9, 2025 | Thorell Marella | Other D | 2.9K | — |
| Oct 9, 2025 | BERGER FRANKLIN M | Other D | 784.4K | — |
| Oct 9, 2025 | Parkinson David Ross KEY | Other D | 65.7K | — |
| Oct 9, 2025 | Martin John Alexander | Other D | 14.3K | — |
| Aug 5, 2025 | BVF INC/IL | Exercise X | 2.9M3 lots | $0 |
| Aug 5, 2025 | BVF INC/IL | Exercise X | 2.9M3 lots | $0 |
| Aug 5, 2025 | BVF INC/IL | Sell S | 1563 lots | $293 |
Buy Sell Non-market (grant · exercise · gift)
About EPIX insider trading
This page tracks insider transactions for ESSA Pharma Inc. (EPIX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.